Literature DB >> 9929742

Each step during transendothelial migration of flowing neutrophils is regulated by the stimulatory concentration of tumour necrosis factor-alpha.

P Bahra1, G E Rainger, J L Wautier, L Nguyet-Thin, G B Nash.   

Abstract

Migration of circulating neutrophils occurs in several steps: capture and rolling adhesion are followed by activation of beta 2-integrins and immobilisation, and then neutrophils move over and through the endothelium. However, it is not clear how the underlying mechanisms and completion of each step depend on the concentration of stimulatory cytokines such as tumour necrosis factor-alpha (TNF). We therefore perfused neutrophils over human umbilical vein endothelial cells (HUVEC) which had been cultured with varying concentration of TNF (1-1000 U/ml) for 4 h, and recorded adhesion and migration by videomicroscopy. The number of adherent neutrophils increased with increasing TNF up to 5 U/ml, but changed little at higher concentrations. Interestingly, rolling adhesion at first predominated, but an increasing proportion of adherent cells became immobilised and migrated through the HUVEC monolayer over the complete TNF range. Immobilisation was inhibited by treating neutrophils with antibody against CD18, so that the major change in adhesive behaviour at higher levels of TNF occurred because the surface of the HUVEC presented agent(s) able to activate neutrophil beta 2-integrins. It was also evident that the selectins initiating capture of flowing neutrophils varied with concentration of TNF. At 100 U/ml TNF, both E-selectin and P-selectin supported capture and rolling adhesion, and antibody blockade of both receptors was required to inhibit adhesion. At lower dose (10 U/ml TNF), stable adhesion was blocked by antibody against E-selectin, although short-lived attachments could still be seen which were inhibited by antibody against P-selectin. Expression of sclectins increased with increasing concentration of TNF, judging from surface ELISA and reduction in the velocity of rolling adherent cells. Thus the efficiency of capture, the selectins mediating capture and the proportion of captured cells immobilised and migrating all depend on the concentration of TNF to which endothelial cells are exposed. These results suggest a model in which highly localised and efficient migration of neutrophils is achieved if a concentration gradient of TNF exists around an inflammatory locus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9929742     DOI: 10.3109/15419069809010797

Source DB:  PubMed          Journal:  Cell Adhes Commun        ISSN: 1023-7046


  16 in total

1.  Immunoglobulin subclass determines ability of immunoglobulin (Ig)G to capture and activate neutrophils presented as normal human IgG or disease-associated anti-neutrophil cytoplasm antibody (ANCA)-IgG.

Authors:  T Pankhurst; G Nash; J Williams; R Colman; A Hussain; C Savage
Journal:  Clin Exp Immunol       Date:  2011-03-10       Impact factor: 4.330

2.  Analyzing the effects of stromal cells on the recruitment of leukocytes from flow.

Authors:  Hafsa Munir; G Ed Rainger; Gerard B Nash; Helen McGettrick
Journal:  J Vis Exp       Date:  2015-01-07       Impact factor: 1.355

3.  Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis.

Authors:  Sohail Malek; Emel Kaplan; Ju-Feng Wang; Qingen Ke; Jamal S Rana; Yu Chen; Bilal G Rahim; Ma Li; Qin Huang; Yong-Fu Xiao; Freek W A Verheugt; James P Morgan; Jiang-Yong Min
Journal:  Pflugers Arch       Date:  2006-01-26       Impact factor: 3.657

4.  Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion.

Authors:  L M Butler; H C Jeffery; R L Wheat; P C Rae; K Townsend; K R Alkharsah; T F Schulz; G B Nash; D J Blackbourn
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

5.  Differing mechanisms of leukocyte recruitment and sensitivity to conditioning by shear stress for endothelial cells treated with tumour necrosis factor-alpha or interleukin-1beta.

Authors:  Sajila Sheikh; Mahbub Rahman; Zoe Gale; N Thin Luu; Philip C W Stone; Nick M Matharu; G Edward Luu Rainger; Gerard B Nash
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

6.  Ontogenetic regulation of leukocyte recruitment in mouse yolk sac vessels.

Authors:  Markus Sperandio; Elizabeth J Quackenbush; Natalia Sushkova; Johannes Altstätter; Claudia Nussbaum; Stephan Schmid; Monika Pruenster; Angela Kurz; Andreas Margraf; Alina Steppner; Natalie Schweiger; Lubor Borsig; Ildiko Boros; Nele Krajewski; Orsolya Genzel-Boroviczeny; Udo Jeschke; David Frommhold; Ulrich H von Andrian
Journal:  Blood       Date:  2013-03-22       Impact factor: 22.113

7.  Delay of migrating leukocytes by the basement membrane deposited by endothelial cells in long-term culture.

Authors:  Victoria J Burton; Lynn M Butler; Helen M McGettrick; Phil C Stone; Hannah C Jeffery; Caroline O Savage; G Ed Rainger; Gerard B Nash
Journal:  Exp Cell Res       Date:  2010-11-04       Impact factor: 3.905

8.  Chemokine- and adhesion-dependent survival of neutrophils after transmigration through cytokine-stimulated endothelium.

Authors:  Helen M McGettrick; Janet M Lord; Ke-Qing Wang; G Ed Rainger; Christopher D Buckley; Gerard B Nash
Journal:  J Leukoc Biol       Date:  2006-02-03       Impact factor: 4.962

9.  Omega-3 Fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment.

Authors:  Samantha P Tull; Clara M Yates; Benjamin H Maskrey; Valerie B O'Donnell; Jackie Madden; Robert F Grimble; Philip C Calder; Gerard B Nash; G Ed Rainger
Journal:  PLoS Biol       Date:  2009-08-25       Impact factor: 8.029

10.  Fibroblasts from different sites may promote or inhibit recruitment of flowing lymphocytes by endothelial cells.

Authors:  Helen M McGettrick; Emily Smith; Andrew Filer; Stephen Kissane; Michael Salmon; Christopher D Buckley; G Ed Rainger; Gerard B Nash
Journal:  Eur J Immunol       Date:  2009-01       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.